MolecularEnvision


Molecular Envision

Manufacturer for qPCR based 
SARS-CoV-2 Nucleic Acid Test 

Test under development  

Key Features:
Multiplex Assay – N gene and Controls (Positive, Negative and Extraction control)
Ready-to-go Reagents – No Mastermix reagent mixing required.
Sensitivity and Specificity specs
96 and 384 Plate layout
Multiple Platforms (Thermofisher - 7900HT Fast and 7500 Real-Time PCR System, QuantStudio™ 3 and 7 Flex systems
Automation friendly – Ready to use reagents
Custom Assay Development, Validation and Manufacturing available 

Dr Kent Small

About US

Founder :

Dr. Kent Small is an M.D. and clinical and basic science researcher for over 30 years.   Dr. Small went to Tulane University for medical school and completed his residency and fellowship from Duke University. He has served as a professor in ophthalmology and molecular biology at University of Florida and University of California Los Angeles (UCLA). Dr. Small has been the principal investigator as a part of over 20 NIH and 100 pharmaceutical funded clinical trial grants. Several patents are in his portfolio as well.  Much of his basic science research has been in molecular genetics as well as in molecular diagnostics.  While a tenured professor at UCLA, he studied business entrepreneurship and corporate financing in the MBA program at UCLA Anderson School of Business.  

Register and Learn !

Join our mailing list to receive the latest news and updates from our team

CONTACT FORM

Contact Us - info@molecularenvision.com 

Molecular Envision

 

Manufacturer for qPCR based
SARS-CoV-2 Nucleic Acid Test 


Address :
Molecular Envision
411 N. Central Ave, Suite 115,
Glendale CA 91203
USA

SUBSCRIBE

Get on our mailing list

CONNECT WITH US